Literature DB >> 11502821

X-linked hypophosphatemia attributable to pseudoexons of the PHEX gene.

P T Christie1, B Harding, M A Nesbit, M P Whyte, R V Thakker.   

Abstract

X-linked hypophosphatemia is commonly caused by mutations of the coding region of PHEX (phosphate-regulating gene with homologies to endopeptidases on the X chromosome). However, such PHEX mutations are not detected in approximately one third of X-linked hypophosphatemia patients who may harbor defects in the noncoding or intronic regions. We have therefore investigated 11 unrelated X-linked hypophosphatemia patients in whom coding region mutations had been excluded, for intronic mutations that may lead to mRNA splicing abnormalities, by the use of lymphoblastoid RNA and RT-PCRs. One X-linked hypophosphatemia patient was found to have 3 abnormally large transcripts, resulting from 51-bp, 100-bp, and 170-bp insertions, all of which would lead to missense peptides and premature termination codons. The origin of these transcripts was a mutation (g to t) at position +1268 of intron 7, which resulted in the occurrence of a high quality novel donor splice site (ggaagg to gtaagg). Splicing between this novel donor splice site and 3 preexisting, but normally silent, acceptor splice sites within intron 7 resulted in the occurrences of the 3 pseudoexons. This represents the first report of PHEX pseudoexons and reveals further the diversity of genetic abnormalities causing X-linked hypophosphatemia.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11502821     DOI: 10.1210/jcem.86.8.7730

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  13 in total

1.  Use of antisense oligonucleotides to correct the splicing error in ISCU myopathy patient cell lines.

Authors:  Gregory P Holmes-Hampton; Daniel R Crooks; Ronald G Haller; Shuling Guo; Susan M Freier; Brett P Monia; Tracey A Rouault
Journal:  Hum Mol Genet       Date:  2016-12-01       Impact factor: 6.150

2.  Detailed molecular characterization of a novel IDS exonic mutation associated with multiple pseudoexon activation.

Authors:  L Grodecká; T Kováčová; M Kramárek; S Seneca; K Stouffs; C De Laet; F Majer; T Kršjaková; P Hujová; K Hrnčířová; P Souček; W Lissens; E Buratti; Tomas Freiberger
Journal:  J Mol Med (Berl)       Date:  2016-11-12       Impact factor: 4.599

3.  A Novel Synonymous Variant of PHEX in a Patient with X-Linked Hypophosphatemia.

Authors:  Xiaosen Ma; Qianqian Pang; Qi Zhang; Yan Jiang; Ou Wang; Mei Li; Xiaoping Xing; Weibo Xia
Journal:  Calcif Tissue Int       Date:  2022-07-14       Impact factor: 4.000

Review 4.  Skeletal and extraskeletal disorders of biomineralization.

Authors:  Michael T Collins; Gemma Marcucci; Hans-Joachim Anders; Giovanni Beltrami; Jane A Cauley; Peter R Ebeling; Rajiv Kumar; Agnès Linglart; Luca Sangiorgi; Dwight A Towler; Ria Weston; Michael P Whyte; Maria Luisa Brandi; Bart Clarke; Rajesh V Thakker
Journal:  Nat Rev Endocrinol       Date:  2022-05-16       Impact factor: 47.564

5.  PHEX analysis in 118 pedigrees reveals new genetic clues in hypophosphatemic rickets.

Authors:  Céline Gaucher; Odile Walrant-Debray; Thy-Minh Nguyen; Laure Esterle; Michèle Garabédian; Frédéric Jehan
Journal:  Hum Genet       Date:  2009-02-15       Impact factor: 4.132

6.  Infertile Finnish Yorkshire boars carry a full-length LINE-1 retrotransposon within the KPL2 gene.

Authors:  Anu Sironen; Johanna Vilkki; Christian Bendixen; Bo Thomsen
Journal:  Mol Genet Genomics       Date:  2007-07-04       Impact factor: 3.291

7.  Determination of the consequences of VHL mutations on VHL transcripts in renal cell carcinoma.

Authors:  Claire Taylor; Rachel A Craven; Patricia Harnden; Peter J Selby; Rosamonde E Banks
Journal:  Int J Oncol       Date:  2012-07-20       Impact factor: 5.650

Review 8.  Defective splicing, disease and therapy: searching for master checkpoints in exon definition.

Authors:  Emanuele Buratti; Marco Baralle; Francisco E Baralle
Journal:  Nucleic Acids Res       Date:  2006-07-19       Impact factor: 16.971

9.  Functional studies on the ATM intronic splicing processing element.

Authors:  Marzena A Lewandowska; Cristiana Stuani; Alireza Parvizpur; Francisco E Baralle; Franco Pagani
Journal:  Nucleic Acids Res       Date:  2005-07-19       Impact factor: 16.971

10.  An Alu-derived intronic splicing enhancer facilitates intronic processing and modulates aberrant splicing in ATM.

Authors:  Tibor Pastor; Gabriele Talotti; Marzena Anna Lewandowska; Franco Pagani
Journal:  Nucleic Acids Res       Date:  2009-11       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.